Latest News

The Analytical Scientist has published an article by our CEO Gordon Hamilton entitled “Welcome to the New Era of Single-Molecule Analysis” which explores new technologies for studying individual biomolecular interactions at unprecedented scale. He explains how we have witnessed remarkable advances in the scale and resolution of genomics, transcriptomics, and proteomics that have generated powerful…

A new Depixus MAGNA One™ instrument has been installed in the VIB Tech Watch Core lab in Ghent, Belgium, with Jérôme Maluenda and Christopher Cleavelin from our science and engineering teams overseeing the installation. Based on Magnetic Force Spectroscopy (MFS), Depixus MAGNA one delivers direct, dynamic data on thousands of individual biomolecular interactions. The first…

A new Depixus MAGNA One™ instrument has been installed for the nucleic acid biochemists at the University of Portsmouth Institute of Life Sciences & Healthcare. Based on Magnetic Force Spectroscopy (MFS), Depixus MAGNA one delivers direct, dynamic data on thousands of individual biomolecular interactions. The researchers will be using the power of our platform to…

In this interview with The Analytical Scientist, CEO Gordon Hamilton talks about the innovations behind our flagship Depixus MAGNA One™ instrument that make magnetic force spectroscopy (MFS) scalable and accessible for the first time, and how it can deliver novel insights with the potential to transform our understanding of health and disease. Gordon says, “As…

Depixus unveils MAGNA One: World’s first laboratory instrument for analyzing individual biomolecular interactions at scale

New study demonstrates power of Depixus’ scalable single molecule interactomics platform to accelerate RNA-targeted drug development

New study highlights utility of Depixus’ single molecule interactomics technology to explore compounds targeting expanded RNA repeats